STANDARD BIOTOOLS INC. — Director's Dealing 2012

Mar 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2012-03-01

Reporting Person: JONES ROBERT C (Exec. VP, Research & Dev.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-01	Common Stock	M	7000	$3.3908	Acquired	7000	Direct
2012-03-01	Common Stock	S	7000	$14.1043	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-01	Employee Stock Option (Right to Buy)	$3.3908	M	7000	Disposed	2015-08-02	Common Stock (7000)	Direct
2012-03-05	Employee Stock Option (Right to Buy)	$14.55	A	10000	Disposed	2022-03-05	Common Stock (10000)	Direct
2009-11-17	Employee Stock Option (Right to Buy)	$4.09	A	5780	Disposed	2019-11-17	Common Stock (5780)	Direct

Footnotes

F1: The sales reported by Mr. Jones were effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2012.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The shares subject to the Option fully vested on August 1, 2009.

F4: 1/24 of the shares subject to the Option vested on the date of grant and 1/48 of the shares subject to the Option will vest on April 1, 2012 and each month thereafter, such that the Option will be fully vested on January 1, 2016.

F5: The Option is not a new grant but is listed herein to correct the vesting schedule previously reported on a Form 3 filed by the reporting person on February 9, 2011. The filed Form 3 reported that 70% of the shares subject to the Option vested on December 31, 2009, 25% of the remaining 30% of the shares subject to the Option vested on April 1, 2010 and 1/48th of the remaining unvested shares subject to the Option shall vest each month thereafter. However, such Form 3 should have reported that 61% of the shares subject to the Option vested on December 31, 2009, 25% of the remaining 39% of the shares subject to the Option vested on April 1, 2010 and 1/48th of the remaining 39% of the shares subject to the Option shall vest each month thereafter such that all shares subject to the Option shall be fully vested on April 1, 2013.

F6: Reflects a 1-for-1.73 reverse stock split of the Issuer's outstanding shares effected February 3, 2011.